These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin ...